Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jook Yuen Low currently holds 17,390 shares of BioNexus Gene Lab Corp (BGLC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jook Yuen Low has been a net neutral trader of BGLC stock. They have purchased $0 and sold $0 worth of shares.
Jook Yuen Low's most recent insider trade was on Aug 13, 2026, when they sold 16,129 shares at $0.00 per share.
Jook Yuen Low serves as Executive at BioNexus Gene Lab Corp (BGLC). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Jook Yuen Low holds the position of Executive at BioNexus Gene Lab Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Jook Yuen Low has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jook Yuen Low was on Aug 13, 2026, when they purchased $0 worth of BGLC shares. This transaction involved 16,129 shares at N/A per share.
Jook Yuen Low currently owns 17,390 shares of BioNexus Gene Lab Corp (BGLC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jook Yuen Low's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jook Yuen Low has 1 Form 4 filings on record as an insider at BioNexus Gene Lab Corp.
Set alerts for Jook Yuen Low and 40,000+ other insiders.